This bill amends the Social Security Act to require states to establish and enforce child support obligations from biological fathers for unborn children, directly affecting mothers expecting a child and the fathers of those children. Key provisions include allowing mothers to request support starting from the month of conception (as confirmed by a physician), permitting retroactive payments even after birth if paternity is later established, and requiring court determination of payment amounts considering the mother's and child's best interests. The bill prohibits mandatory paternity testing without the mother's consent and bans any procedures posing risk to the unborn child. It defines "unborn child" as any human fetus at any developmental stage carried in the womb, with the law taking effect two years after enactment.
The DTC Act of 2025 requires pharmaceutical companies to disclose the wholesale acquisition cost (WAC) for a 30-day supply (or typical treatment course) of prescription drugs in direct-to-consumer advertisements. This applies to drugs covered by Medicare or Medicaid, excluding those with a WAC under $35 per 30-day supply. The bill mandates clear, conspicuous display of the WAC in ads, along with a note that actual patient costs may vary based on insurance coverage. It takes effect July 1, 2026, and includes penalties for noncompliance, such as civil fines up to $100,000 per violation. The law aims to increase price transparency for consumers seeing drug ads, particularly affecting patients with high-deductible plans or Medicare beneficiaries.
HR 679 nullifies specific changes the Food and Drug Administration (FDA) made in January 2023 to the safety rules (REMS) for the abortion pill mifepristone. The bill prohibits the FDA from implementing any future safety rules for mifepristone that are substantially similar to the nullified changes. This directly affects the FDA's regulatory authority over mifepristone, which could impact how healthcare providers prescribe the medication and how patients access it. The bill focuses solely on reversing the FDA's 2023 modifications without altering the drug's broader approval status.
HR 685, the SAVE Moms and Babies Act of 2025, prohibits the FDA from approving new abortion drugs or allowing investigational use of existing ones. It restricts existing abortion drugs to in-person administration by certified healthcare providers in clinics or hospitals (not pharmacies), limits use to pregnancies under 70 days gestation, and requires providers to certify they can handle complications like severe bleeding or ectopic pregnancies. The bill mandates reporting of adverse events (such as hospitalizations or infections) to the FDA without patient identifiers and defines "abortion drug" broadly as any drug intended to terminate pregnancy, excluding specific medical exceptions. This directly affects FDA approval processes, healthcare providers prescribing these drugs, and drug manufacturers.
HR 645, the National Constitutional Carry Act, would prevent all U.S. states and localities from requiring permits or imposing penalties for carrying firearms in public. It directly affects eligible U.S. citizens (including non-residents) who legally possess firearms under state and federal law, removing current permit requirements for public carry. The bill’s key provision amends federal law to invalidate any state or local law that criminalizes or discourages public firearm carry, except where private property owners clearly prohibit firearms or security screening occurs. This would override existing state permit laws, making permitless carry legal across all states and territories for qualified individuals.
HR 703, the Main Street Tax Certainty Act, makes a key tax deduction permanent for small business owners. It removes the temporary sunset provision (subsection (i)) from Section 199A of the tax code, ensuring the qualified business income deduction remains available for eligible small businesses. This change directly affects pass-through business owners (like S-corps, partnerships, and sole proprietorships) who currently qualify for this deduction. The permanent change takes effect for tax years starting after December 31, 2025.
HR 682, the Heartbeat Protection Act of 2025, prohibits physicians from performing abortions without first checking for a detectable fetal heartbeat according to standard medical practice and informing the patient of the results. It directly affects physicians and clinics performing abortions, requiring them to document heartbeat checks and comply with strict exceptions for life-threatening conditions, rape (with 48-hour documentation of counseling/treatment), or incest involving minors (with proof of prior report to authorities). Violations could result in fines or up to five years in prison, though the bill explicitly states it does not create or recognize a right to abortion. The law adds detailed documentation requirements for exceptions and mandates retention of medical records per federal health privacy rules.
This bill prohibits U.S. federal funds from being used to support the United Nations Population Fund (UNFPA). It bans all contributions - direct or indirect - from any department or agency, including the State Department, that might reach the UNFPA. The law directly affects how federal agencies manage international aid budgets and prevents taxpayer money from flowing to the UNFPA. It does not alter existing funding for other UN programs or create new requirements.
HR 648, the Strengthening our Servicemembers with Milk Act, requires the Secretary of Defense to provide a variety of milk options - including unflavored, organic, lactose-free, and different fat levels - to all members of the Armed Forces at military dining facilities. The bill mandates that installations offer these choices to support servicemember nutrition and dietary needs. It also prohibits purchasing milk from entities owned or controlled by foreign adversaries, as defined by Commerce Department regulations. This policy directly affects military personnel dining at on-base facilities nationwide.
HJRES 28 proposes a constitutional amendment to permanently fix the number of justices on the U.S. Supreme Court at nine. This would require ratification by 38 state legislatures (three-fourths of states) within seven years to become part of the Constitution. The amendment directly affects the structure of the Supreme Court, which has had nine justices since 1869 but could otherwise be altered by future congressional action. It does not change current court operations or create new laws, but instead seeks to make the nine-justice composition a permanent constitutional requirement.
SRES 30 is a ceremonial Senate resolution honoring Mississippi's Gestational Age Act, introduced by Senator Cindy Hyde-Smith and others on January 22, 2025. It expresses gratitude to Mississippi State Representative Becky Currie for introducing the 2018 law that banned abortions after 15 weeks gestation, which later became central to the Supreme Court's 2022 *Dobbs v. Jackson Women's Health* decision overturning *Roe v. Wade*. The resolution does not create new laws or alter abortion access but formally recognizes Mississippi's role in the legal shift. It is purely symbolic, with no policy impact, and acknowledges the state law as a catalyst for the Supreme Court's ruling.
HRES 56 is a non-binding resolution proposing to memorialize unborn children by encouraging the public to lower the U.S. flag to half-staff on January 22 each year. It cites the anniversary of Roe v. Wade's 1973 ruling and the 2022 overturning of that decision, referencing the claim that over 62 million unborn children have "perished" since 1973. The resolution specifically urges the public to observe this day as the "Day of Tears," encourages flag lowering to "mourn and honor" those affected, and promotes legislative efforts to "affirm the sanctity of life" regarding abortion. As a symbolic gesture, it does not create new law but seeks to influence public observance. The resolution was introduced by multiple House members and referred to the Oversight Committee.
